纤维肌痛治疗市场：按分销管道和地区划分

2025 年全球纤维肌痛治疗市场规模估计为 31.8 亿美元，预计到 2032 年将达到 40.5 亿美元，2025 年至 2032 年的复合年增长率为 3.5%。

数字。 2025 年纤维肌痛治疗市场占有率（按地区划分）

纤维肌痛症是一种以肌肉、韧带和肌腱的慢性广泛性疼痛和压痛为特征的疾病。它常伴随疲劳、睡眠障碍、记忆问题和情绪障碍。纤维肌痛的具体病因尚不清楚，但人们认为它是由大脑的神经化学失衡引起的。这些症状会对患者的生活品质产生负面影响。目前，纤维肌痛尚无治癒方法，但治疗旨在控制症状和改善日常功能。常见的治疗方法包括药物治疗、改变生活方式、替代疗法和认知行为疗法。由于诊断率上升和对疾病意识的提高，全球纤维肌痛治疗市场预计将显着增长。

市场动态：

全球纤维肌痛治疗市场受到全球纤维肌痛盛行率上升的推动。据估计，纤维肌痛影响着全球约 2-8% 的人口。此外，用于治疗纤维肌痛的新药物配方的核准越来越多，也推动了市场的成长。然而，高昂的治疗费用和缺乏成熟的治疗方法阻碍了市场潜力。另一个问题是医生缺乏意识。市场先驱有机会开发治疗纤维肌痛的新配方并提供经济实惠的治疗选择。生物製药的日益普及也将开闢新的成长途径。

本研究的主要特点

• 本报告对全球纤维肌痛治疗市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模（BN$）和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它还强调了各个领域的潜在商机并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 全球纤维肌痛治疗市场的主要企业已根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行了分析。
• 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
• 全球纤维肌痛治疗市场报告针对该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员将透过用于分析全球纤维肌痛治疗市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 市场机会
• 影响分析
• 管道分析
• 专利诉讼
• 赎回
• 专利格局（ANDA/NDA Intelligence）
• PEST分析
• 波特的分析

4. 全球纤维肌痛治疗市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020 年至 2032 年全球纤维肌痛治疗市场（按药物类别划分）（十亿美元）

• 抗忧郁症
• 抗惊厥药
• 肌肉鬆弛剂
• 止痛药
• 其他的

6. 2020-2032 年全球纤维肌痛治疗市场按分销管道划分（十亿美元）

• 医院药房
• 零售药局
• 网路药局

7. 2020 年至 2032 年全球纤维肌痛治疗市场（按地区划分）（十亿美元）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第八章 竞争格局

• 热图分析
• 公司简介
  • Eli Lilly and Company
  • Pfizer, Inc.
  • Novartis AG
  • Allergan plc
  • Sun Pharmaceutical Industries Ltd.
  • Aptinyx, Inc.
  • Prismic Pharmaceuticals, Inc.
  • Innovative Med Concepts, Inc.
  • Intec Pharma Ltd
  • Astellas Pharma Inc.
  • Johnson &Johnson
  • GSK
  • AstraZeneca plc
  • Bristol Myers Squibb
  • Viatris
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Sanofi

第 9 章 分析师观点

第十章参考文献与调查方法

• 参考
• 调查方法

Global Fibromyalgia Treatment Market is estimated to be valued at USD 3.18 Bn in 2025 and is expected to reach USD 4.05 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.5% from 2025 to 2032.

Figure. Fibromyalgia Treatment Market Share (%), By Region 2025

Fibromyalgia is a disorder characterized by chronic widespread pain and tenderness in the muscles, ligaments and tendons. It is often accompanied by fatigue, sleep issues, memory and mood issues. The exact cause of fibromyalgia is still unknown but is believed to be due to neurochemical imbalance in the brain. The symptoms negatively impact quality of life of those suffering from it. Currently there is no cure for fibromyalgia but the treatment aims to manage symptoms and improve day to day functioning. Some of the common treatment options include medications, lifestyle changes, alternate therapies, cognitive behavior therapy etc. The global fibromyalgia treatment market is expected to witness significant growth due to the increasing diagnosis rates and growing awareness about the condition.

Market Dynamics:

The global fibromyalgia treatment market is driven by the rising prevalence of fibromyalgia worldwide. As per estimates, fibromyalgia affects about 2-8% of the global population. Moreover, increasing approval of new drug formulations for fibromyalgia treatment is also boosting the market growth. However, high cost of treatment therapies and lack of cure hinders the market potential. Lack of awareness among physicians also poses a challenge. The market players have opportunities to develop novel drug formulations for fibromyalgia cure and offer treatment options at affordable prices. Increasing adoption of biologics also opens new growth avenues.

Key Features of the Study:

• This report provides in-depth analysis of the global fibromyalgia treatment market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global fibromyalgia treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Eli Lilly and Company, Pfizer Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx Inc., Prismic Pharmaceuticals Inc., Innovative Med Concepts Inc., Intec Pharma Ltd., Astellas Pharma Inc., Johnson & Johnson, GSK, AstraZeneca plc, Bristol Myers Squibb, Viatris, Takeda Pharmaceutical Company Limited, Amgen Inc., and Sanofi.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global fibromyalgia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibromyalgia treatment market.

Market Segmentation

• Drug Class:
  • Antidepressants
  • Antiepileptics
  • Muscle Relaxants
  • Analgesics
  • Others
• Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Regional:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Eli Lilly and Company
  • Pfizer Inc.
  • Novartis AG
  • Allergan plc
  • Sun Pharmaceutical Industries Ltd.
  • Aptinyx Inc.
  • Prismic Pharmaceuticals Inc.
  • Innovative Med Concepts Inc.
  • Intec Pharma Ltd.
  • Astellas Pharma Inc.
  • Johnson & Johnson
  • GSK
  • AstraZeneca plc
  • Bristol Myers Squibb
  • Viatris
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Sanofi

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Pipeline Analysis
• Patent Litigations
• Reimbursement
• Patent Landscape (ANDA/NDA Intelligence)
• PEST Analysis
• Porter's Analysis

4. Global Fibromyalgia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Fibromyalgia Treatment Market, By Drug Class, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Antidepressants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
  • Segment Trends
• Antiepileptics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
  • Segment Trends
• Muscle Relaxants
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Analgesics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

6. Global Fibromyalgia Treatment Market, By Distribution Channel, 2020 - 2032, (USD BN)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD BN)

7. Global Fibromyalgia Treatment Market, By Region, 2020 - 2032, (USD BN)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD BN)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD BN)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD BN)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pfizer, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Allergan plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Aptinyx, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Prismic Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Innovative Med Concepts, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Intec Pharma Ltd
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Astellas Pharma Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Market Strategies
  • GSK
  • AstraZeneca plc
  • Bristol Myers Squibb
  • Viatris
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Sanofi

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact